Mesoblast Limited's market cap is currently $2.49B. The company's EPS TTM is $-0.043; its P/E ratio is -22.46; Mesoblast Limited is scheduled to report earnings on August 28, 2025, and the estimated EPS forecast is gt;-0.01. See an overview of income statement, balance sheet, and cash flow financials.
